I started studying cancer immune therapies in 2011 at the University of Pennsylvania where I obtained my PhD in Cell and Molecule Biology- Gene Therapy and Vaccines in 2016. I developed several therapies in my mentor's (Daniel J. Powell Jr.) lab including a B7-H4 CAR, HER2 TCR, and initiated a veterinary clinical trial in pet dogs to treat B cell lymphoma with a CD20 CAR. After graduate school, I ventured to Poseida Therapeutics in San Diego- leading their P-PSMA-101 program and several other projects. I am currently leading a Process Development team in San Francisco at Arsenal Biosciences.
I am most interested in assisting and promoting the SITC community!